Clinical Trial Update: Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

This is a post-marketing Phase 4 safety and tolerability study of Breztri Aerosphere in Indian patients with moderate to severe chronic obstructive pulmonary di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Moderate to Severe COPD | Phase 4 | Status: RECRUITING